1. A method of making a solid pharmaceutical composition containing the active substance rasagiline vklyuchayuschiyrastvorenie pharmaceutically acceptable salts of rasagiline in an aqueous solvent to obtain a rasagiline salt solution, applying a solution of a salt of rasagiline on a solid carrier, wherein the pH of the salt solution rasagiline achieved using pharmaceutically acceptable acid adjusted to less than 3,5.2. The method of claim. 1, characterized in that the salt of rasagiline is an acid addition solyu.3. A method according to claim. 2, characterized in that the anionic component of the acid addition salt is different from the corresponding anion kisloty.4. The method of claim. 1, characterized in that a salt of rasagiline tartrate razagilina.5. The method of claim. 1, characterized in that the acid is phosphoric acid (HPO) .6. The method of claim. 1, characterized in that the pH of rasagiline salt solution with an acid is adjusted to from 2 to 1.7. The method of claim. 1, characterized in that the carrier is microcrystalline cellulose or sodium starch glycolate krahmala.8. The aqueous mixture in which is present in dissolved form, a pharmaceutically acceptable salt of rasagiline, pH 3,0.9 less. A mixture according to claim. 8, wherein the pH is set using kisloty.10. A solid pharmaceutical composition obtained by the method described in claims. 1 - 7.11. A solid pharmaceutical composition comprising rasagiline farmtsevticheski acceptable salt thereof, and a pharmaceutically acceptable acid with an exponent pKa acidity of at least 3.1. Способ получения твердой фармацевтической композиции, содержащей действующее вещество разагилин, включающийрастворение фармацевтически приемлемых солей разагилина в водном растворителе с получением раствора соли разагилинананесение раствора соли разагилина на твердый носитель,отличающийся тем, что значение рН раствора соли разагилина, достигаемое при помощи фармацевтически приемлемой кислоты, доводят до уровня менее 3,5.2. Сп
